Medical Device News Magazine

Christopher Holland Appointed Electromed Chief Commercial Officer – 30+Years of Experience

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Christopher Holland, an accomplished sales and marketing veteran, brings 30 years of experience in driving commercial growth in the Medical Technology market to Electromed.

Prior to joining Electromed, Holland was the Vice President of Commercialization at Prosomnus Sleep Technologies, Inc., a Medical Device manufacturer of a mandibular advancement device for sleep apnea where he led new product introduction and revenue-growth initiatives across the enterprise.

Prior to his time at Prosomnus, Christopher Holland spent over a decade as the Chief Commercial Officer and Executive Vice President of Sales and Global Business Development at Nonin Medical, Inc., where his accomplishments included delivering record global sales by successfully initiating and leading a corporate commercial turnaround. Earlier in his career, Holland held various leadership roles at Cisco Systems and PriceWaterhouseCoopers.

“We are thrilled to welcome Christopher Holland to our team at an exciting time,” said Kathleen Skarvan, Chief Executive Officer. “The Chief Commercial Officer is a strategic and value-added role for Electromed that will strengthen marketing, sales strategy and execution in support of our revenue growth goals, ultimately enhancing shareholder value. After conducting a lengthy and diligent search, we are confident that Chris is the ideal person to lead these strategic efforts.”

“I am very excited to be joining the Electromed team,” said Mr. Holland. “I believe Electromed has a best-in-class product and a very talented management team, which uniquely positions the company for growth in an under-served market. I look forward to guiding the Company’s strategic growth initiatives, while optimizing return on investment, and am delighted to work closely with Kathleen and her team to bring Electromed to the forefront of the airway clearance market.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”